RA Capital Management's Life Science Portfolio

Aktis Oncology is a biotechnology company that designs and develops novel class radiopharmaceuticals.

Hyku is a biotech company that develops precise covalent targeting of disease-causing proteins.

Synapse Energy Economics is a consulting firm providing economic and policy analysis for the electric power sector.

Navigator Medicines operate as a biotech company.

GentiBio is a biotherapeutics company developing engineered regulatory T cells programmed to treat autoimmune allergic diseases.

Ocelot Bio brings new treatment options to patients with severe liver disease.

Element Biosciences develops genomic sequencing and multiomics technologies used in drug discovery, and diagnostic applications.

Black Diamond Therapeutics is a medical company focused on analyzing genetically defined cancers.

ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.

Frontier Medicines is a biopharmaceutical company that develops a chemoproteomics platform to accelerate the development of medicines.

Taysha Gene Therapies develops treatments to eradicate severe and life-threatening monogenic diseases of the central nervous system.

Scribe Therapeutics is a biotech company that develops and engineers new therapeutics based on CRISPR molecules.

Legend Biotech is a biopharmaceutical company that develops and commercializes novel cell therapies for oncology.

Parabilis Medicines is a Grupo Bugio is a biopharmaceutical firm that specializes in creating medicines.

Artiva Biotherapeutics is a biotech company focused on developing and commercializing allogeneic natural killer (NK) cell therapies.

Windward Bio develops monoclonal antibodies for advanced immunological diseases.

Apogee Therapeutics is a biotechnology company that offers therapies for immunological and inflammatory disorders.

Boundless Bio is a precision oncology company that develops therapeutics directed against extrachromosomal DNA in aggressive cancers.

Sana Biotechnology is a developer of engineered cells intended to be used as medicine for patients.

Werewolf Therapeutics operates as an oncology biotherapeutics company.

Stipple Bio is a biotechnology company that offers cellular profiling and target discovery with epitope resolution.

Atavistik Bio is a biotechnology company that develops precision allosteric small molecules aimed at treating metabolic diseases and cancer.

OnKure is a clinical-stage biopharma company developing precision medicines targeting validated cancer drivers.

Inhibrx is a clinical-stage biotechnology company that focuses on developing a broad pipeline of biologic therapeutic candidates.

Equillium is a biotechnology company that develops products for autoimmune and inflammatory disorders with an unmet medical need.

Compass Pathways is a mental health care company that focuses on developing therapies for treatment-resistant depression.

Zura Bio is a clinical-stage, multi-asset biotechnology company.

Bicara Therapeutics develops dual-action cancer therapies, combining targeted treatments with tumor modulators for enhanced impact.

Tyra Biosciences is a biotechnology company targeting new pathways of acquired resistance in oncology with purpose-built drugs.

Synthego is a genome engineering company that enables access to CRISPR to accelerate life science research and development.

Immunic is a biopharmaceutical company that develops a pipeline of selective oral immunology therapies.

Evommune is a biotechnology company that develops therapeutics that halt progressive disease and address their symptoms.

Hemab is a clinical-stage biotech company that develops prophylactic biologic therapies for underserved bleeding and thrombotic.

Ansa Biotechnologies develops a novel DNA synthesis technology based on enzymes.

Delix Therapeutics focuses on harnessing the power of psychoplastogens novel neuroplasticity-promoting therapeutic.

Gameto is a biotechnology company developing therapeutics of the female reproductive system using cell engineering.

Imbria Pharmaceuticals is a clinical stage biotechnology company developing novel therapies for cardiometabolic diseases.

Bambusa Therapeutics operates as biotechnology company.

Trace Neuroscience is a biopharmaceutical company that aims to extend the promise of genetic medicine to patients.

Idrx is a clinical-stage biopharmaceutical that develops oncology-based precision therapies to treat cancer.

Outpace Bio develops innovative cell therapies to enhance cancer treatment efficacy.

Bright Peak is a biotech company that develops a portfolio of immunotherapies for the treatment of cancer and autoimmune diseases.

Ajax Therapeutics is a biotechnology company developing therapies to target cytokine signaling pathways that drive hematologic malignancies.

ExcepGen is solving fundamental underlying problems in drug discovery to create a new generation of therapeutics.

Capacity Bio is a therapeutics company that is focused on mitophagy.

Diagonal Therapeutics is a biotechnology startup that develops targeted therapies for cancer and genetic diseases.

Synthekine is a development stage biotherapeutics company focused on the engineering of novel specific and potent cytokine therapies.

Nautilus Biotechnology is a life sciences company that develops a platform for analyzing and quantifying the human proteome.

Pardes Biosciences is a biotechnology company that develops and commercializes direct-acting antivirals for the treatment of coronavirus.

Third Harmonic Bio is a clinical-stage company developing a first-in-class, highly selective, and oral kit inhibitor.

BioAge Labs is a clinical-stage biotechnology company that develops therapeutics to treat obesity and metabolic diseases.

New Amsterdam is a clinical-stage company focused on the research and development of transformative therapies for cardio-metabolic diseases.

Verve Therapeutics is a clinical-stage biotechnology company developing genetic medicines for cardiovascular disease.

Affinia Therapeutics is a biotechnology company developing transformative AAV gene therapies for people with rare and prevalent diseases.

LEXEO Therapeutics utilizes gene therapy to treat genetically defined cardiovascular and central nervous system diseases.

Design Therapeutics is a biotechnology company developing a new class of therapies for serious degenerative disorders.

AavantiBio is a biopharmaceutical company that provides gene transfer and gene editing therapies to treat genetic diseases.

Aerovate Therapeutics is a biotechnology company focused on developing drugs for rare cardiopulmonary disease.

OvaScience is a life sciences company focused on the discovery, development and commercialization of treatments for infertility.